Alan B. Lancz & Associates, Inc. Gsk PLC Transaction History

Alan B. Lancz & Associates, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$42.05 - $47.77 $623,391 - $708,190	-14,825 Closed	0 $0
Q4 2021 Apr 13, 2022	SELL	$38.88 - $45.31 $3.5 Million - $4.08 Million	-90,000 Reduced 85.86%	14,825 $654,000
Q4 2021 Feb 09, 2022	BUY	$38.88 - $45.31 $4.08 Million - $4.75 Million	104,825 New	104,825 $4.62 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Alan B. Lancz & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Alan B. Lancz & Associates, Inc. with notifications on news.